Arjun Balar, SVP and Head of Oncology Global Clinical Development at Eli Lilly and Company, shared a post on LinkedIn: “I’m happy to share that I’m starting a new position … Read More
Feb 03, 2026
Wafaa M Rashed, Chair and Founder of Pan-African PGS Education and Research Initiative, shared a post on LinkedIn: “Group 1 Affirmative Team This video features the Affirmative Team from Group 1, … Read More
Feb 02, 2026
Rishabh Jain, Medical Oncologist at AIIMS, shared a post on X: “KRAS is no longer “undruggable”. A new Cancer Cell review maps how KRAS inhibitors are reshaping therapy across lung, colorectal, … Read More
Feb 02, 2026
Christos Tsagkaris, Orthopedic Surgery Resident at Solothurner Hospitals AG – soH, shared a post on LinkedIn: “Medicine fulfils its purpose not when knowledge exists, but when knowledge can be acted upon … Read More
Feb 02, 2026
EIOC – Excellence in Oncology Care shared a post on LinkedIn: “Precision oncology is evolving, and so should our treatment strategies. Join the EIOC Journal Club for an expert-led discussion … Read More
Feb 02, 2026
Guillermo Chantada, Head of the Outreach Program at Hospital Sant Joan de Déu and Scientific Director of the Perez Scremini Foundation, shared a post by OncoDaily, on LinkedIn, adding: “It … Read More
Feb 02, 2026
Hellenic Cancer Federation | ELLOK shared a post on LinkedIn: “Conference Highlights! What does a well-organized lung cancer care pathway mean for the patient and their caregivers? How can early diagnosis, access … Read More
Feb 02, 2026
Amalya Sargsyan, Head of Intelligence Unit at OncoDaily, Medical Oncologist at Yeolyan Hematology and Oncology Center, and Clinical Research Physician at Immune Oncology Research Institute, shared a post on LinkedIn: “Happy … Read More
Feb 02, 2026
Natera announced on February 2, 2026 that it has submitted a Premarket Approval (PMA) application to the U.S. FDA for Signatera™ CDx to detect molecular residual disease (MRD) in muscle-invasive … Read More
Feb 02, 2026
Cathy Eng, VICC Associate Director of Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, shared a post on X: “Leading the charge…my former boss and former National Cancer Institute Director … Read More
Feb 02, 2026